AT352874B - Verfahren zur herstellung von neuen amino- derivaten der clavulansaeure - Google Patents

Verfahren zur herstellung von neuen amino- derivaten der clavulansaeure

Info

Publication number
AT352874B
AT352874B AT753476A AT753476A AT352874B AT 352874 B AT352874 B AT 352874B AT 753476 A AT753476 A AT 753476A AT 753476 A AT753476 A AT 753476A AT 352874 B AT352874 B AT 352874B
Authority
AT
Austria
Prior art keywords
clavulanic acid
producing new
amino derivatives
new amino
derivatives
Prior art date
Application number
AT753476A
Other languages
English (en)
Other versions
ATA753476A (de
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of ATA753476A publication Critical patent/ATA753476A/de
Application granted granted Critical
Publication of AT352874B publication Critical patent/AT352874B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
AT753476A 1975-10-13 1976-10-11 Verfahren zur herstellung von neuen amino- derivaten der clavulansaeure AT352874B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB41887/75A GB1566706A (en) 1975-10-13 1975-10-13 Clavulanic acid derivatives

Publications (2)

Publication Number Publication Date
ATA753476A ATA753476A (de) 1979-03-15
AT352874B true AT352874B (de) 1979-10-10

Family

ID=10421810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT753476A AT352874B (de) 1975-10-13 1976-10-11 Verfahren zur herstellung von neuen amino- derivaten der clavulansaeure

Country Status (28)

Country Link
US (3) US4256638A (de)
JP (1) JPS5248686A (de)
AR (1) AR213294A1 (de)
AT (1) AT352874B (de)
AU (1) AU503489B2 (de)
BE (1) BE847044A (de)
CA (1) CA1094563A (de)
CH (2) CH634323A5 (de)
DD (1) DD126929A5 (de)
DE (1) DE2646003A1 (de)
DK (1) DK457676A (de)
ES (2) ES452361A1 (de)
FI (1) FI762895A (de)
FR (1) FR2327775A1 (de)
GB (1) GB1566706A (de)
GR (1) GR61674B (de)
HU (1) HU175046B (de)
IE (1) IE43840B1 (de)
IL (1) IL50618A (de)
MX (1) MX4688E (de)
NL (1) NL7611206A (de)
NO (3) NO763472L (de)
NZ (1) NZ182190A (de)
PT (1) PT65707B (de)
SE (3) SE7611047L (de)
SU (1) SU639454A3 (de)
ZA (1) ZA765901B (de)
ZM (1) ZM12276A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7711961L (sv) * 1976-10-25 1978-06-15 Glaxo Lab Ltd Forfarande for framstellning av antibiotika
GB1604822A (en) 1977-04-22 1981-12-16 Beecham Group Ltd N-monosubstituted-9-amino-9-deoxyclavulanic acid derivative
US4359473A (en) 1977-04-22 1982-11-16 Beecham Group Limited α-Amino deoxy clavulanic acid antibacterial agents
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
EP0005014A1 (de) * 1978-04-22 1979-10-31 Beecham Group Plc Clavulansäure-Derivate, Herstellung und Zusammensetzungen
DE2963534D1 (en) * 1978-07-29 1982-10-07 Beecham Group Plc Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them
EP0009302B1 (de) * 1978-09-09 1983-10-26 Beecham Group Plc Clavulansäure-Derivate und Verfahren zu ihrer Herstellung
EP0008877B1 (de) * 1978-09-09 1983-10-26 Beecham Group Plc Clavulansäure-Derivate, ein Verfahren zu ihrer Herstellung und ihre Zusammensetzungen
EP0008884B1 (de) * 1978-09-09 1983-08-17 Beecham Group Plc Clavulansäure-Derivate, ein Verfahren zu ihrer Herstellung und ihre Zusammensetzungen
DE2965938D1 (en) 1978-10-25 1983-08-25 Beecham Group Plc Clavulanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them
IL60343A0 (en) * 1979-07-02 1980-09-16 Beecham Group Ltd Clavulanic acid derivatives,their preparation and pharmaceutical compositions containing them
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
DE3066511D1 (en) * 1979-10-26 1984-03-15 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and pharmaceutical compositions containing them
EP0053893B1 (de) * 1980-12-09 1985-03-20 Beecham Group Plc Clavulansäure-Derivate, ihre Herstellung und ihre Verwendung
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
JPS57143194A (en) * 1981-02-27 1982-09-04 Matsushita Electric Ind Co Ltd Blower
EP0062407A1 (de) * 1981-03-10 1982-10-13 Beecham Group Plc Beta-Lactame enthaltende therapeutische Verbindungen
JPH0495698U (de) * 1991-01-21 1992-08-19
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1424186A (en) * 1971-10-08 1976-02-11 Beecham Group Ltd Penicillins
US3925363A (en) * 1974-01-17 1975-12-09 Merck & Co Inc Process for epimerizing penicillin compounds, and related products
US4051132A (en) * 1974-01-23 1977-09-27 Merck & Co., Inc. Process for epimerizing beta-lactam antibiotic compounds by means of an acid quench
GB1585165A (en) * 1976-06-29 1981-02-25 Leo Pharm Prod Ltd Derivatives of 6-amidino penicillanic acid
IL54859A (en) * 1977-06-21 1982-01-31 Rech Applications Therap Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
EP0005348B1 (de) * 1978-05-06 1982-09-22 Beecham Group Plc Carbapenemderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
US4244965A (en) * 1978-06-15 1981-01-13 Beecham Group Limited Azetidinoyl ethers
US4252722A (en) * 1979-08-08 1981-02-24 Merck & Co., Inc. Process for the preparation of 6-hydroxymethyl-2-(β-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylic acid
US4237051A (en) * 1979-04-19 1980-12-02 Schering Corporation Stereospecific production of 6- or 7-carbon-substituted-β-lactams
US4231928A (en) * 1979-04-24 1980-11-04 Bristol-Myers Company Antibacterial agents

Also Published As

Publication number Publication date
IE43840B1 (en) 1981-06-03
US4438101A (en) 1984-03-20
FR2327775A1 (fr) 1977-05-13
GB1566706A (en) 1980-05-08
SE7611047L (sv) 1977-04-14
US4256638A (en) 1981-03-17
CA1094563A (en) 1981-01-27
PT65707B (en) 1978-04-17
ES452361A1 (es) 1978-01-01
MX4688E (es) 1982-08-02
ZA765901B (en) 1977-09-28
SU639454A3 (ru) 1978-12-25
ZM12276A1 (en) 1977-07-21
AU1858276A (en) 1978-04-20
CH634323A5 (de) 1983-01-31
NZ182190A (en) 1979-03-16
IE43840L (en) 1977-04-13
FR2327775B1 (de) 1978-11-17
GR61674B (en) 1978-12-05
PT65707A (en) 1976-11-01
NO802662L (no) 1977-04-14
DD126929A5 (de) 1977-08-24
ES463974A1 (es) 1978-12-16
HU175046B (hu) 1980-05-28
CH639665A5 (de) 1983-11-30
IL50618A0 (en) 1976-12-31
NO763472L (de) 1977-04-14
SE8004329L (sv) 1980-06-10
US4382084A (en) 1983-05-03
DE2646003A1 (de) 1977-04-21
ATA753476A (de) 1979-03-15
FI762895A (de) 1977-04-14
JPS612670B2 (de) 1986-01-27
JPS5248686A (en) 1977-04-18
SE8004330L (sv) 1980-06-10
BE847044A (fr) 1977-04-07
NO802661L (no) 1977-04-14
AU503489B2 (en) 1979-09-06
NL7611206A (nl) 1977-04-15
DK457676A (da) 1977-04-14
IL50618A (en) 1979-09-30
AR213294A1 (es) 1979-01-15

Similar Documents

Publication Publication Date Title
AT352874B (de) Verfahren zur herstellung von neuen amino- derivaten der clavulansaeure
AT360005B (de) Verfahren zur herstellung von neuen sulfonyl- benzimidazolderivaten
ATA283676A (de) Verfahren zur herstellung von neuen phenylalkancarbonsaure-derivaten
AT362085B (de) Verfahren zur herstellung von neuen 16- -dehydroandrostan-derivaten
AT344163B (de) Verfahren zur herstellung von neuen oxadiazolinon-derivaten
AT360006B (de) Verfahren zur herstellung von neuen thiazolinylbenzimidazolderivaten
AT355723B (de) Verfahren zur herstellung von neuen oxim- derivaten der 7-aminothiazolylacetamido- cephalosporansaeure
AT347453B (de) Verfahren zur herstellung von neuen 5-phenyl- oxazolidinon-2-derivaten
AT357671B (de) Verfahren zur herstellung von neuen oxim- derivaten der 3-carbamoyloxymethyl-7-amino- thiazolylacetamido-cephalosporansaeure
AT356814B (de) Verfahren zur herstellung von neuen clavulan- saeurederivaten
ATA72977A (de) Verfahren zur herstellung von neuen derivaten der 3-carbamoyloxy-methyl-7-(amino-4- thiazolyl-acetamido)-cepahlosporansaeure
AT355722B (de) Verfahren zur herstellung von neuen oxim- derivaten der 3-thiadiazolyl -thiomethyl-7-amino-thiazolyl-acetamido- cephalosporansaeure
AT348677B (de) Verfahren zur herstellung von neuen thiadiazolyl-derivaten der 7-acylamido-3-cephem-4-carbonsaeure
AT358168B (de) Verfahren zur herstellung von neuen substituierten n-methylenderivaten des thienamycins
AT347963B (de) Verfahren zur herstellung von neuen 4- halogenazetidinon-1-essigsaeurederivaten
AT363181B (de) Verfahren zur herstellung von neuen clavulansaeurederivaten
AT342078B (de) Verfahren zur herstellung von neuen vinylthionophosphorsaureestern
AT343291B (de) Verfahren zur herstellung von neuen quartaren xanthinylalkyl-nortropinderivaten
AT354653B (de) Verfahren zur herstellung von neuen d-homosteroiden
AT350555B (de) Verfahren zur herstellung von neuen additions- salzen von thiazol-5-methanolderivaten
AT349476B (de) Verfahren zur herstellung von neuen phenoxy- alkancarbonsaeurederivaten von 1-cinnamyl-4- diphenylmethylpiperazin
AT356813B (de) Verfahren zur herstellung von neuen penicillin- derivaten
AT344145B (de) Verfahren zur herstellung von neuen derivaten der 3-phenyl-2-chlorpropionsaeure
AT353280B (de) Verfahren zur herstellung von neuen 3- -sulfonyloxy-crotonsaeureazetidinon-2-derivaten
AT358177B (de) Verfahren zur herstellung von neuen oxim- derivaten der 3-thiadiazolyl-thiomethyl-7- -amino-thiazolyl-acetamido-cephalosporansaeure